Latent class analysis of human herpesvirus 8 assay performance and infection prevalence in sub-saharan Africa and Malta.

Engels, E A; Sinclair, M D; Biggar, R J; Whitby, D; Ebbesen, P; Goedert, J J; Gastwirth, J L

Engels, E A; Sinclair, M D; Biggar, R J; Whitby, D; Ebbesen, P; Goedert, J J; Gastwirth, J L.

Affiliation

Engels EA; Viral Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA. engelse@exchange.nih.gov

Int J Cancer ; 88(6): 1003-8, 2000 Dec 15.

Article in En | MEDLINE | ID: mdl-11093828

Subject(s)

Herpesviridae Infections/epidemiology; Herpesvirus 8, Human/isolation & purification; Sarcoma, Kaposi/epidemiology; Adolescent; Adult; Aged; Botswana/epidemiology; Case-Control Studies; Child; Congo/epidemiology; Female; Fluorescent Antibody Technique; Humans; Immunoenzyme Techniques; Incidence; Male; Malta/epidemiology; Middle Aged; Prevalence; Sensitivity and Specificity; Viral Proteins/analysis

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Sarcoma, Kaposi / Herpesviridae Infections / Herpesvirus 8, Human Type of study: Diagnostic_studies / Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Child / Female / Humans / Male / Middle aged Country/Region as subject: Africa / Europa Language: En Journal: Int J Cancer Year: 2000 Document type: Article

Search on Google

XML

PubMed Links